Clinical Study
Early Stage Oropharyngeal Carcinomas: Comparing Quality of Life for Different Treatment Modalities
Table 2
EORTC-QLQ-C30 scores for all three treatment groups.
| |
Item | OP | OPRT | OPRCT | | Median (95%-confidence interval of mean) | Median (95%-confidence interval of mean) | Median (95%-confidence interval of mean) |
| | Global health status | 75.00 (62.79–80.16) | 66.67 (56.85–72.95) | 66.67 (59.22–70.91) | | Functional scales | | | | | Physical | 100 (87.33–97.28) | 86.67 (75.34–88.30) | 93.33 (79.68–91.66) | | Role | 100 (85.28–98.05) | 83.33 (58.70–82.71) | 83.33 (64.70–81.46) | | Emotional | 83.33 (72.59–88.95) | 75.00 (59.79–80.79) | 83.33 (66.66–80.99) | | Cognitive | 100 (80.90–96.02) | 83.33 (68.77–87.80) | 100 (76.23–89.79) | | Social | 100 (78.80–98.13) | 83.33 (64.59–85.92) | 100 (71.26–86.43) | | Symptom scales | | | | | Fatigue | 16.67 (13.25–31.20) | 22.22 (20.16–41.45) | 27.78 (22.09–39.02) | | Nausea and vomiting | 0 (−0.68–1.96) | 0 (2.39–11.75) | 0 (1.78–9.76) | | Pain | 0 (5.16–21.77) | 16.67 (18.31–39.26) | 16.67 (17.18–34.75) | | Dyspnea | 0 (9.79–33.80) | 0 (8.53–29.86) | 0 (11.15–27.31) | | Insomnia | 0 (14.64–41.77) | 0 (11.24–35.23) | 0 (16.52–37.33) | | Appetite loss | 0 (−1.08–16.47) | 0 (8.12–30.26) | 0 (8.68–27.22) | | Constipation | 0 (2.26–20.82) | 0 (5.68–28.66) | 0 (3.16–16.07) | | Diarrhea | 0 (1.94–18.57) | 0 (2.15–14.01) | 0 (1.37–10.16) | | Financial problems | 0 (−2.17–20.11) | 0 (7.74–24.58) | 0 (12.26–28.76) |
|
|
